Evidence map›Paper›PMID 25124322›Full record

ArticleCirculation research2014

Ceramide signaling in the coronary microcirculation: a double-edged sword?

Brian R Weil, John M Canty

Abstract readEditorialComment
In one paragraph

Article in Circulation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Brian R WeilFrom the Departments of Medicine, Biomedical Engineering, and Physiology and Biophysics, The Veterans Affairs Western New York Healthcare System and the Clinical and Translational Research Center at the University at Buffalo.
John M CantyFrom the Departments of Medicine, Biomedical Engineering, and Physiology and Biophysics, The Veterans Affairs Western New York Healthcare System and the Clinical and Translational Research Center at the University at Buffalo. canty@buffalo.edu.

Funding

Metabolic Adaptation and Functional Recovery of Hibernating MyocardiumR01HL061610 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CANTY, JOHN M · 2000 to 2018
$6.0M
CHRONIC ADAPTATIONS TO MYOCARDIAL ISCHEMIAR01HL055324 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CANTY, JOHN M · 1996 to 2014
$4.2M
Amplification of Cardiosphere-Derived Cell TherapyF32HL114335 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI WEIL, BRIAN RAYMOND · 2013 to 2015
$159k
NHLBI NIH HHS F32 HL114335NHLBI NIH HHS F32HL-114335NHLBI NIH HHS HL-055324NHLBI NIH HHS HL-061610NHLBI NIH HHS R01 HL055324NHLBI NIH HHS R01 HL061610
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adipose TissueCoronary Artery DiseaseCoronary CirculationCoronary VesselsFemaleHumansHydrogen PeroxideMaleMicrocirculationNitric OxideSphingosineVasodilationHydrogen PeroxideN-acetylsphingosineNitric OxideSphingosineceramidesEditorialsmicrocirculation

Identifiers

PMID25124322
PMCPMC4181843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.